LVM Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $566K | Hold |
1,128
| – | – | 0.05% | 113 |
|
|
2026
Q1 | $554K | Hold |
1,128
| – | – | 0.05% | 106 |
|
|
2025
Q4 | $654K | Sell |
1,128
-33
| -3% | -$18.7K | 0.06% | 96 |
|
|
2025
Q3 | $563K | Sell |
1,161
-3
| -0.3% | -$1.4K | 0.05% | 108 |
|
|
2025
Q2 | $472K | Hold |
1,164
| – | – | 0.05% | 117 |
|
|
2025
Q1 | $579K | Hold |
1,164
| – | – | 0.06% | 97 |
|
|
2024
Q4 | $606K | Buy |
1,164
+3
| +0.3% | +$1.65K | 0.07% | 98 |
|
|
2024
Q3 | $642K | Hold |
1,161
| – | – | 0.07% | 96 |
|
|
2024
Q2 | $642K | Buy |
1,161
+100
| +9% | +$57.3K | 0.07% | 96 |
|
|
2024
Q1 | $617K | Hold |
1,061
| – | – | 0.07% | 97 |
|
|
2023
Q4 | $563K | Hold |
1,061
| – | – | 0.07% | 98 |
|
|
2023
Q3 | $537K | Hold |
1,061
| – | – | 0.08% | 91 |
|
|
2023
Q2 | $554K | Sell |
1,061
-654
| -38% | -$353K | 0.07% | 93 |
|
|
2023
Q1 | $988K | Sell |
1,715
-50
| -3% | -$28.2K | 0.14% | 68 |
|
|
2022
Q4 | $972K | Hold |
1,765
| – | – | 0.14% | 69 |
|
|
2022
Q3 | $895K | Sell |
1,765
-50
| -3% | -$28K | 0.14% | 70 |
|
|
2022
Q2 | $986K | Hold |
1,815
| – | – | 0.14% | 68 |
|
|
2022
Q1 | $1.07M | Hold |
1,815
| – | – | 0.14% | 66 |
|
|
2021
Q4 | $1.21M | Sell |
1,815
-291
| -14% | -$182K | 0.16% | 63 |
|
|
2021
Q3 | $1.2M | Sell |
2,106
-87
| -4% | -$47.8K | 0.18% | 62 |
|
|
2021
Q2 | $1.11M | Hold |
2,193
| – | – | 0.17% | 62 |
|
|
2021
Q1 | $1M | Hold |
2,193
| – | – | 0.16% | 62 |
|
|
2020
Q4 | $1.02M | Buy |
2,193
+10
| +0.5% | +$4.69K | 0.17% | 60 |
|
|
2020
Q3 | $964K | Hold |
2,183
| – | – | 0.19% | 52 |
|
|
2020
Q2 | $791K | Hold |
2,183
| – | – | 0.16% | 54 |
|
|
2020
Q1 | $619K | Hold |
2,183
| – | – | 0.15% | 56 |
|
|
2019
Q4 | $709K | Hold |
2,183
| – | – | 0.14% | 58 |
|
|
2019
Q3 | $636K | Hold |
2,183
| – | – | 0.14% | 61 |
|
|
2019
Q2 | $641K | Hold |
2,183
| – | – | 0.15% | 58 |
|
|
2019
Q1 | $598K | Hold |
2,183
| – | – | 0.14% | 60 |
|
|
2018
Q4 | $489K | Sell |
2,183
-333
| -13% | -$78.1K | 0.13% | 62 |
|
|
2018
Q3 | $614K | Hold |
2,516
| – | – | 0.14% | 63 |
|
|
2018
Q2 | $521K | Hold |
2,516
| – | – | 0.13% | 65 |
|
|
2018
Q1 | $519K | Hold |
2,516
| – | – | 0.12% | 65 |
|
|
2017
Q4 | $478K | Hold |
2,516
| – | – | 0.11% | 69 |
|
|
2017
Q3 | $476K | Hold |
2,516
| – | – | 0.11% | 67 |
|
|
2017
Q2 | $439K | Sell |
2,516
-334
| -12% | -$56.1K | 0.11% | 71 |
|
|
2017
Q1 | $438K | Hold |
2,850
| – | – | 0.11% | 72 |
|
|
2016
Q4 | $402K | Sell |
2,850
-40
| -1% | -$5.9K | 0.11% | 73 |
|
|
2016
Q3 | $341K | Buy |
2,890
+40
| +1% | +$6.16K | 0.11% | 78 |
|
|
2016
Q2 | $421K | Hold |
2,850
| – | – | 0.12% | 70 |
|
|
2016
Q1 | $404K | Hold |
2,850
| – | – | 0.13% | 67 |
|
|
2015
Q4 | $404K | Hold |
2,850
| – | – | 0.14% | 62 |
|
|
2015
Q3 | $348K | Hold |
2,850
| – | – | 0.13% | 71 |
|
|
2015
Q2 | $370K | Hold |
2,850
| – | – | 0.12% | 71 |
|
|
2015
Q1 | $383K | Hold |
2,850
| – | – | 0.13% | 69 |
|
|
2014
Q4 | $357K | Hold |
2,850
| – | – | 0.12% | 76 |
|
|
2014
Q3 | $347K | Sell |
2,850
-40
| -1% | -$4.86K | 0.11% | 77 |
|
|
2014
Q2 | $341K | Buy |
2,890
+40
| +1% | +$4.71K | 0.11% | 78 |
|
|
2014
Q1 | $343K | Hold |
2,850
| – | – | 0.12% | 80 |
|
|
2013
Q4 | $317K | Hold |
2,850
| – | – | 0.11% | 86 |
|
|
2013
Q3 | $263K | Hold |
2,850
| – | – | 0.1% | 90 |
|
|
2013
Q2 | $241K | Buy |
+2,850
| New | +$237K | 0.1% | 100 |
|
Other funds holding TMO
RG
ECSS
LT
LVM Capital Management's TMO Position: Q2 2026 in Review
LVM Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,128 shares worth $566K. The position accounts for 0.05% of the portfolio, ranked #113.
LVM Capital Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.21M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- LVM Capital Management held 1,128 shares of Thermo Fisher Scientific worth $566K as of Q2 2026.
- LVM Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.05% of LVM Capital Management's portfolio in Q2 2026, its #113 holding.
- LVM Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- LVM Capital Management's Thermo Fisher Scientific position peaked at $1.21M in Q4 2021.
- 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on LVM Capital Management's 13F filing for Q2 2026, filed 9 Jul 2026.